Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial.
J Pineal Res
; 73(1): e12809, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35619221
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin Resistance
/
Diabetes Mellitus, Type 2
/
Melatonin
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
J Pineal Res
Journal subject:
ENDOCRINOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Denmark
Country of publication:
United kingdom